Technavio, a tech-focused market research firm, has published a new report on the global human RSV drugs market, which is expected to experience a steady growth rate with a CAGR of more than 4% during the forecast period 2016-2020. This latest report by Technavio covers the market outlook and growth prospects of the global…
According to the latest market research study released by Technavio, the global alopecia drugs market is expected to grow at a CAGR of more than 5% during the forecast period 2016-2020. This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report…
Technavio, a tech-focused market research firm, has published a new report on the global gout therapeutics market, which is expected to experience a slow but steady growth rate with a CAGR of around 9% during the forecast period 2016-2020. This latest report by Technavio covers the market outlook and growth prospects of the global…
According to the latest market research study released by Technavio, the global hemophilia drugs market is expected to grow at a CAGR of more than 5% during the forecast period 2016-2020. This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report…
The global animal antibacterial and antibiotics market will grow at a CAGR of almost 6% by 2020, thanks to the growing administration of Tetracyclines Technavio’s infections and rare diseases portfolio has announced its latest market research report on animal antibacterial and antibiotics for the forecast period, 2016-2020. This market analysis discusses the major drivers and key emerging…
MRSA drugs: Key market research findings Increasing prevalence of infections Increased funding for antibiotic research Key vendors include Allergan, Merck, Pfizer, and Theravance Biopharma Technavio has released a new report on the global MRSA drugs market, which is predicted to surpass $3 billion during the forecast period. The global methicillin-resistant Staphylococcus aureus (MRSA) drugs…
Asthma therapeutics: Key market research findings The Americas dominates the market geographically Inhalation is the largest ROA segment Key vendors – AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, and Merck Technavio’s market research analysts predict the global market for asthma therapeutics to grow at a CAGR of around 5% between 2016 and 2020. The…
Allergy immunotherapies: Key market research findings Presence of high unmet medical needs spurs growth in the market Europe dominates the market geographically Key vendors – ALK-Abello, Stallergenes, Merck Group, and Allergy Therapeutics Technavio’s market research analysts predict the global allergy immunotherapies market to grow at a CAGR of more than 7% between 2016 and…
COPD drugs in China: Key market research findings The rise in healthcare expenditure in the country boosts the demand for COPD drugs The bronchodilators segment accounts for the majority share of the market’s revenue Key vendors – AstraZeneca, Boehringer Ingelheim, GSK, Merck, and Novartis Technavio’s market research analysts predict the COPD drugs market in…
Infectious disease treatment: Key market research findings Increasing levels of pollutants and chemicals is the primary driver for the market Increase in number of collaborations and M&As Key vendors—F. Hoffmann-La Roche, Gilead Sciences, GSK, Johnson & Johnson, Merck, and Pfizer Technavio’s market research analysts estimate the infectious disease treatment market in China to grow…
